Project description
Overcoming personalised medicine challenges
The European Advanced Translational Research Infrastructure in Medicine (EATRIS) provides integrated access to the combined expertise and high-end technologies for developing new products in translational medicine. During its first five years, it provided its services to a wide range of users such as academia, SMEs, large pharma and biotech research institutes. The EU-funded EATRIS-Plus project intends to support the long term sustainability (LTS) of the EATRIS by offering advanced scientific instruments to the academic community, improving its financial model and strengthening its leadership in the field of personalised medicine (PM). The project will be implemented in 16 EU countries supporting the collection and utilisation of translational academic abilities in omic technologies to increase research on the scientific and societal challenges related to PM.
Objective
In the first five years of operations, EATRIS has shown strong proof of concept of the value of the services portfolio, with users ranging from academia, SMEs, large pharma, to biotech and research funding organisations. The overarching aim of EATRIS-Plus is to support the long-term sustainability (LTS) of EATRIS by delivering innovative scientific tools to the research community, strengthening the infrastructure’s financial model and reinforcing EATRIS leadership in the European Research Area (ERA), particularly in the field of Personalised Medicine (PM) research and development.
Specific objectives are: (i) To consolidate EATRIS capacities in the field of PM to better serve academia and industry and augment the number of EATRIS Innovation Hubs with large pharma; (ii) To further strengthen the LTS of EATRIS financial model; (iii) To drive patient empowerment through active involvement in the infrastructure’s operations; (iv) To expand strategic partnerships with Research Infrastructures and other relevant stakeholders. The proposal relies on a scientific and technological programme combined with capacity-building activities across 16 EU countries, with the support of two umbrella organisations representing patient organisations and SMEs.
EATRIS-Plus will help pooling and exploiting the translational academic capacities of the infrastructure in omic technologies to enable researchers to better address the scientific and societal challenge of PM. Additionally, the coordination office and 13 existing national nodes of the infrastructure will participate in implementing joint outreach, training, industry engagement and international collaboration activities to further build national capacity, increase users’ trust and strengthen EATRIS and the ERA global scientific leadership.
Keywords
Programme(s)
Topic(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
1081 HZ Amsterdam
Netherlands
See on map
Participants (25)
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
601 77 Brno
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
20132 Milano
See on map
771 47 Olomouc
See on map
28046 MADRID
See on map
00014 Helsingin Yliopisto
See on map
1445 Strassen
See on map
Participation ended
6525 XZ Nijmegen
See on map
1000 Ljubljana
See on map
D02 CX56 DUBLIN 2
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
2 Dublin
See on map
1007 Riga
See on map
751 05 Uppsala
See on map
81675 Muenchen
See on map
BRUSSELS Brussels / Bruxelles
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
40237 Dusseldorf
See on map
08035 Barcelona
See on map
75015 PARIS 15
See on map
00161 Roma
See on map
0313 Oslo
See on map
08028 Barcelona
See on map
1749 004 Lisboa
See on map
1504 Sofia
See on map
10000 ZAGREB
See on map
6525 GA Nijmegen
See on map
70211 KUOPIO
See on map